N-Nitroso Varenicline
98%
- Product Code: 214995
CAS:
2755871-02-2
| Molecular Weight: | 240.26 g./mol | Molecular Formula: | C₁₃H₁₂N₄O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
N-Nitroso Varenicline is primarily of concern due to its potential formation as a nitrosamine impurity in pharmaceutical products containing varenicline, an active ingredient used to aid smoking cessation. Nitrosamine impurities like N-Nitroso Varenicline are classified as probable human carcinogens based on animal studies, raising significant safety and regulatory concerns. As such, its main relevance lies in quality control and risk assessment during drug manufacturing. Regulatory agencies require strict limits on its presence in medications, prompting manufacturers to implement sensitive analytical methods to detect and control trace levels. Efforts are focused on minimizing formation during synthesis and storage, particularly under conditions where nitrosating agents may be present. Its application, therefore, is not functional but rather a critical consideration in pharmaceutical safety and compliance.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 25mg | 10-20 days | ฿47,200.00 |
+
-
|
N-Nitroso Varenicline
N-Nitroso Varenicline is primarily of concern due to its potential formation as a nitrosamine impurity in pharmaceutical products containing varenicline, an active ingredient used to aid smoking cessation. Nitrosamine impurities like N-Nitroso Varenicline are classified as probable human carcinogens based on animal studies, raising significant safety and regulatory concerns. As such, its main relevance lies in quality control and risk assessment during drug manufacturing. Regulatory agencies require strict limits on its presence in medications, prompting manufacturers to implement sensitive analytical methods to detect and control trace levels. Efforts are focused on minimizing formation during synthesis and storage, particularly under conditions where nitrosating agents may be present. Its application, therefore, is not functional but rather a critical consideration in pharmaceutical safety and compliance.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :